Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

The CARs that ate hospitals

- Featured Image

The Australian Commission on Safety and Quality in Health Care has released its latest six-monthly report for the National Alert System for Critical Antimicrobial Resistance (CARAlert) system, which shows the continuing threat of antimicrobial resistance by dangerous bacteria.

The two key findings in the report highlight the prevalence of Carbapenemase-producing Enterobacteriaceae or CPE (in the hospital setting) and Neisseria gonorrhoeae (in the community).

The report found that:

  • Continued volume of CPE reports (255 in 6 months to 31 March) highlight the importance of effective infection prevention and control to help combat the threat of antimicrobial resistance.
  • For the first time, two extensively drug-resistant gonorrhoeae infections have been reported in Australia, following a report in the United Kingdom of a similar strain.
  • 653 CARs were reported by 58 participating laboratories between October 2017 and 31 March 2018 – a similar number to same period in previous year.
  • 48 per cent of CARs were detected from patients attending hospitals.

The report is at www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/what-is-aura/national-alert-system-for-critical-antimicrobial-resistances-caralert/